VEEVA SYSTEMS INC VEEV 76.64
Health Care · NYSE · Data as of 2026-08-27
VEEVA SYSTEMS INC (VEEV) has delivered +22.0% annualized revenue growth, +26.4% earnings growth, and n/a dividend growth over 10 years of data. Ranked #158 of 1968 stocks overall and #13 of 260 in the Health Care sector by Steady Score.
About VEEVA SYSTEMS INC
Company Overview
Veeva Systems provides cloud software, data and services for the life sciences industry. Pharmaceutical, biotechnology and medical-device companies use its products to manage clinical development, regulatory content, quality processes, safety, commercial customer relationships and industry data. The portfolio spans Veeva Development Cloud, Quality Cloud, Commercial Cloud and Data Cloud, supporting work from research and product approval through marketing and sales.
Read more
Business Model & Revenue
Veeva earns most revenue from subscription services that give customers continuing access to its cloud applications and data products. Contracts generally charge fees based on factors such as users, products, records or data access, depending on the offering. Professional services provide implementation, configuration and consulting and form a smaller revenue stream. Commercial Solutions and R&D and Quality Solutions divide revenue by the business processes they support.
Key Facts & Market Position
The company focuses primarily on the regulated life sciences sector rather than serving software buyers across all industries. Its applications share cloud platforms and industry data, allowing customers to use related products across development, quality and commercialization. Long product validation and migration projects can deepen operational use, while customer budgets, regulation and competition from general-purpose and specialized vendors shape demand.